Skip to main content

Advertisement

SpringerLink
Log in

Gastrectomy + Cytoreductive Surgery + HIPEC for Gastric Cancer with Peritoneal Dissemination (PERISCOPE II)

  • ASO Research Letter
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.

    Article  PubMed  Google Scholar 

  2. Rijken A, Lurvink RJ, Luyer MDP, et al. The burden of peritoneal metastases from gastric cancer: a systematic review on the incidence, risk factors and survival. J Clin Med. 2021;10(21):4882. https://doi.org/10.3390/jcm10214882.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Green BL, Blumenthaler AN, Gamble LA, et al. Cytoreduction and HIPEC for gastric carcinomatosis: multi-institutional analysis of two phase II clinical trials. Ann Surg Oncol. 2023;30(3):1852–60. https://doi.org/10.1245/s10434-022-12761-0.

    Article  PubMed  Google Scholar 

  4. Rudloff U, Langan RC, Mullinax JE, et al. Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: results of the GYMSSA trial. J Surg Oncol. 2014;110(3):275–84. https://doi.org/10.1002/jso.23633.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Koemans WJ, van der Kaaij RT, Boot H, Buffart T, Veenhof AA, Hartemink KJ, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II). BMC Cancer. 2019;19(1):420. https://doi.org/10.1186/s12885-019-5640-2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Koemans WJ, Houwink A, van der Kaaij RT, Wassenaar EC, Boerma D, Hahn C, et al. Perioperative management of gastric cancer patients treated with (sub)total gastrectomy, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy (HIPEC): lessons learned. Ann Surg Oncol. 2021;28(8):4647–54. https://doi.org/10.1245/s10434-020-09465-8.

    Article  CAS  PubMed  Google Scholar 

  7. van der Kaaij RT, Wassenaar ECE, Koemans WJ, et al. Treatment of PERItoneal disease in stomach cancer with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: PERISCOPE I initial results. Br J Surg. 2020;107(11):1520–8. https://doi.org/10.1002/bjs.11588.

    Article  CAS  PubMed  Google Scholar 

  8. Koemans WJ, van der Kaaij RT, Wassenaar ECE, et al. Tumor characteristics and clinical outcome of peritoneal metastasis of gastric origin treated with a hyperthermic intraperitoneal chemotherapy procedure in the PERISCOPE I trial. J Surg Oncol. 2021;123(4):904–10. https://doi.org/10.1002/jso.26366.

    Article  PubMed  Google Scholar 

  9. Beate R, Brandl A, Piso P, Pelz J, Busch P, Demtröder C, et al. Peritoneal metastasis in gastric cancer: results from the German database. Gastr Cancer. 2020;23(1):11–22. https://doi.org/10.1007/s10120-019-00978-0.

    Article  Google Scholar 

  10. Chia CS, You B, Decullier E, Vaudoyer D, Lorimier G, Abboud K, et al. Patients with peritoneal carcinomatosis from gastric cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Is cure a possibility? Ann Surg Oncol. 2016;23(6):1971–9. https://doi.org/10.1245/s10434-015-5081-3.

    Article  CAS  PubMed  Google Scholar 

  11. Manzanedo I, Pereira F, Rihuete Caro C, Pérez-Viejo E, Serrano Á, Gutierrez Calvo A, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for gastric cancer with peritoneal carcinomatosis: multicenter study of spanish group of peritoneal oncologic surgery (GECOP). Ann Surg Oncol. 2019;26(8):2615–21. https://doi.org/10.1245/s10434-019-07450-4.

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

The PERISCOPE II study is funded by the Dutch Cancer Society and The Netherlands Organisation for Health Research and Development.

Author information

Authors and Affiliations

  1. Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

    Amber Leila Sarvestani MD, Stephanie N. Gregory MD, Sarfraz R. Akmal BS & Jonathan M. Hernandez MD

  2. Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands

    Karen van der Sluis MD & Johanna W. van Sandick MD, PhD

Authors
  1. Amber Leila Sarvestani MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephanie N. Gregory MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sarfraz R. Akmal BS
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jonathan M. Hernandez MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Karen van der Sluis MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Johanna W. van Sandick MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Jonathan M. Hernandez MD or Karen van der Sluis MD.

Ethics declarations

Disclosure

Amber Leila Sarvestani, Stephanie N. Gregory, Sarfraz R. Akmal, Jonathan M. Hernandez, Karen van der Sluis, and Johanna W. van Sandick have no conflicts of interest to declare in relation to this work.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PNG 252 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sarvestani, A.L., Gregory, S.N., Akmal, S.R. et al. Gastrectomy + Cytoreductive Surgery + HIPEC for Gastric Cancer with Peritoneal Dissemination (PERISCOPE II). Ann Surg Oncol 31, 28–30 (2024). https://doi.org/10.1245/s10434-023-14415-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-023-14415-1

Search

Navigation